1,088
Participants
Start Date
November 30, 2004
Primary Completion Date
May 28, 2005
Study Completion Date
May 28, 2005
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain
Single oral application of a fixed combination of Aspirin and Lidocain (as one lozenge)
Acetylsalicylic Acid (Aspirin, BAYE4465)
Single oral application of Aspirin (as lozenge)
Lidocain
Single oral application of Lidocain (as lozenge)
Placebo
Single oral application of Placebo (as lozenge)
Luhansk
Luhansk
Moscow
Moscow
Moscow
Moscow
Moscow
Moscow
Moscow
Moscow
Moscow
Mocow
Moscow
Moscow
Novosibirsk
Kiev
Kiev
Kiev
Kiev
Lead Sponsor
Bayer
INDUSTRY